Results 131 to 140 of about 25,222 (249)

From Guidelines to Clinical Practice: Expert Perspectives on Long‐Term Management of Obesity

open access: yesObesity, Volume 34, Issue 9, Page 1708-1717, September 2026.
ABSTRACT An international panel of experts from the U.S. and China convened to discuss the 2026 TOS–OMA–OAC Expert Guidance Statement on the Pharmacological Management of Obesity, focusing on emerging evidence, regional considerations, and challenges in translating recommendations into long‐term care.
Hong Chen   +5 more
wiley   +1 more source

Molecular Mechanisms of Food Bioactive Constituents in the Management of Obesity and Hypertension: A Critical Review

open access: yesPhytochemicals in Food and Medicine, Volume 1, Issue 3, September 2026.
Obesity and hypertension co‐exist and share molecular mechanisms in terms of dietary therapy, modulated by food bioactive constituents. ABSTRACT Obesity and hypertension are among the most pressing global public health challenges. They frequently co‐exist, with obesity‐related hypertension accounting for an estimated 75% of the hypertension burden ...
Samuel Oluwasegun Maccarthy   +3 more
wiley   +1 more source

PhD

open access: yes, 2007
dissertationDevelopment of a polymeric naltrexone delivery system would give an effective means for treatment of opiate addiction. A novel approach involves synthesis and characterization of a biodegradable polymeric prodrug of naltrexone covalently ...
Bennett, David Bruce
core  

Prenatal testing and postpartum treatment for hepatitis C virus among women with opioid use disorder

open access: yesPregnancy, Volume 2, Issue 5, September 2026.
Abstract Introduction In the past decade, hepatitis C virus (HCV) infections among pregnant women increased dramatically in the United States, rising in parallel with the opioid crisis and increasing the number of children at risk for HCV. People with HCV infection that remains untreated are also at increased risk of cirrhosis, liver cancer, and death.
Lucas Gosdin   +19 more
wiley   +1 more source

A high‐altitude thermal infrared method for estimating moose abundance and demography in Rocky Mountain National Park, USA

open access: yesWildlife Biology, Volume 2026, Issue 5, September 2026.
Resource managers require accurate estimates of large herbivore abundance and demography to maintain ecological integrity. Common methods to count these species, including observations from low altitude helicopter flights, may conflict with other protected area management objectives and struggle to produce precise estimates for more cryptic species. To
Hanem G. Abouelezz, N. Thompson Hobbs
wiley   +1 more source

Monitoring the effects of ovariectomy on seasonal movement behavior in suburban female white‐tailed deer using internet of things‐enabled devices

open access: yesWildlife Biology, Volume 2026, Issue 5, September 2026.
Abundant deer populations often cause conflicts in suburban communities, yet traditional population reduction methods, such as controlled hunting, can be challenging to implement. Fertility control, specifically through ovariectomy, can limit reproduction and reduce populations in certain settings, but its effect on movement behavior remains poorly ...
Vickie DeNicola   +2 more
wiley   +1 more source

Ecology of declining populations of gray foxes (Urocyon cinereoargenteus) in Indiana, USA Ecología de las poblaciones en declive de zorros grises (Urocyon cinereoargenteus) en Indiana, EE.UU.

open access: yesWildlife Monographs, Volume 226, Issue 1, September 2026.
We estimated seasonal space use, cover selection, and resource selection; evaluated gene flow and potential genetic barriers; and assessed cause‐specific survival rates and reproduction of radiomarked gray foxes in Indiana, USA. Our results provide evidence that gray foxes in Indiana are an edge species with relatively large home ranges, relatively low
Tim L. Hiller   +5 more
wiley   +1 more source

Treatment with naltrexone

open access: yes, 1995
The procedures of naltrexone treatment for the maintenance of a drug-free state from opioids are described. Treatment with naltrexone (a competitive antagonist of the opioid receptors with oral activity and long duration of action) must be employed in ...
E. Sternieri, FERRARI, Anna
core  

Home - About - Disclaimer - Privacy